Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline) in Patients With Acute Coronary Syndrome
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by Newark Beth Israel Medical Center.
Recruitment status was  Recruiting
Study NCT01170338   Information provided by Newark Beth Israel Medical Center

First Received on July 26, 2010.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial